Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Cue Biopharma (CUE) Accumulated Depreciation & Amortization (2017 - 2025)

Cue Biopharma (CUE) has disclosed Accumulated Depreciation & Amortization for 9 consecutive years, with $3.7 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization changed 0.46% to $3.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Dec 2025, changed 0.46% year-over-year, with the annual reading at $3.7 million for FY2025, 0.46% changed from the prior year.
  • Accumulated Depreciation & Amortization hit $3.7 million in Q4 2025 for Cue Biopharma, up from $3.6 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $4.6 million in Q3 2023 to a low of $3.0 million in Q2 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $3.8 million across 5 years, with a median of $3.7 million in 2024.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 36.26% in 2021 and later fell 15.86% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $3.4 million in 2021, then grew by 23.18% to $4.2 million in 2022, then dropped by 14.76% to $3.6 million in 2023, then rose by 1.77% to $3.7 million in 2024, then decreased by 0.46% to $3.7 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for CUE at $3.7 million in Q4 2025, $3.6 million in Q3 2025, and $3.9 million in Q2 2025.